Our comprehensive market intelligence report reviews how we understand the biologically aging brain and the solutions neurotech offers.
We are delighted to announce the publication of a brand new market intelligence report that examines technological interventions that interact with the brain and provides a detailed analysis of the significant and growing neurotechnology market.
The report’s Foreword is by NTX Services, a non-profit organisation whose mission is to facilitate the advancement of neurotechnology by providing key resources and learning opportunities, and by being leaders in local and worldwide technological initiatives.
Longevity.Technology: Neurotech helps us to understand brain function, enable visualisation of its processes and – crucially – help to repair or improve its function. With a focus on creating an interface between the nervous system and technological devices, neurotech can monitor and modulate neural activity, both opening a window on the mysterious functioning of the brain and providing a door through which we can provide therapy.
Although neurotechnology is not a new industry, it has been increasingly gaining traction in recent years and the solutions it provides will continue to expand – as they need to. The economic, societal and individual impact of an aging population that experience neurological disorders is already significant and will increasingly place heavy demands on society and health care systems. As the rise in neurological conditions forms the biggest threat, and, as the current treatment strategies for disorders related to the biologically aging brain mostly consist of symptoms management, it is essential to shift the focus elsewhere, and neurotech could offer the needed avenue to address this crisis.
For this report, the Longevity.Technology Brain Trust has focused on the key technologies that underscore the broader categories of neurotech, as well as considering other technologies that will facilitate, enhance and advance the use of neurotech. We consider the Hallmarks of Brain Aging, the rise of neurotech in home and wearable devices, as well as clinical settings and the crossover into areas such as education and gaming.
Neurotech – a unique solution
Neurotech offers a unique solution in the face of an aging population, and the associated rise in neurological conditions, because it can improve detection and diagnosis of conditions, facilitate their treatment – and maybe even provide a solution for their prevention.
Neurotech can help us monitor the impact of our lifestyles and environments on our brain health and can also play a key role in aiding our understanding of pathology – not only early detection of pathology through better screening, but modifying neuronal activity diseases’ early stages to halt their progression and prevent manifestation of symptoms.
Key technologies examined in the report:
- BCI – direct communication pathway between the brain’s electrical activity and an external device, most commonly a computer or robotic limb.
- Neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body.
- Neuroimaging – the methods for the scanning of the brain and spinal cord’s physiological functioning, including the assessment of its anatomical physiological integrity.
- Neuromonitoring / feedback – the use of real-time displays that measure brain waves to produce a signal that can be used as feedback to teach the self-regulation of brain function.
- Advancing neurotechnologies – other technologies that will facilitate, enhance and advance the use of neurotechnologies.
And for investors?
In a given population, the cost of neurological disorders already exceeds those associated with cardiovascular diseases and cancer – and it is not only healthcare expenses that contribute to this burden. The impact of neural diseases can also cause a loss of productivity in the workplace and have a significant impact on families.
With these driving factors, it is no wonder that the importance of neurotechnology (neurotech) is being recognised internationally by governments, and countries with accentuated aging population problems are at the forefront of those focusing investment in this field.
Our report examines the top neurotech deals of 2021, considers data, safety and regulation risks, and details neurotech start-ups, capital invested and deal count.
Our report also features neurotech trailblazers – dynamic and innovative companies we feel are driving this exciting space.